MYGN

SEC source: 0001788981-23-000002 · wk-form4_1685743652.xml · nonDerivative · entry 1

Newcomer Lee Nisley · CIK 0001788981 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,850

F1 · kind: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001471518-23-000004 · wk-form4_1685743243.xml · nonDerivative · entry 1

Phanstiel S. Louise · CIK 0001471518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,953

F1 · kind: Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant.

SEC source: 0001517026-23-000002 · wf-form4_168177016388393.xml · nonDerivative · entry 1

Verratti Mark · CIK 0001517026 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 262,704

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 14, 2023.

SEC source: 0001922964-23-000003 · wf-form4_168177002190556.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,217

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 14, 2023.

SEC source: 0001770252-23-000004 · wf-form4_168003861168211.xml · nonDerivative · entry 1

Lambert Nicole · CIK 0001770252 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240,506

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on November 9, 2022.

SEC source: 0001628280-23-009266 · wf-form4_167994891597024.xml · nonDerivative · entry 2

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,029

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009266 · wf-form4_167994891597024.xml · nonDerivative · entry 3

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,446

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009266 · wf-form4_167994891597024.xml · nonDerivative · entry 1

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,394

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009264 · wf-form4_167994889776174.xml · nonDerivative · entry 2

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,855

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009264 · wf-form4_167994889776174.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,400

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009263 · wf-form4_167994888071580.xml · nonDerivative · entry 2

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,249

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009263 · wf-form4_167994888071580.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,923

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009262 · wf-form4_167994886476875.xml · nonDerivative · entry 2

Verratti Mark · CIK 0001517026 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 263,407

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009262 · wf-form4_167994886476875.xml · nonDerivative · entry 1

Verratti Mark · CIK 0001517026 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 264,993

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009261 · wf-form4_167994884975705.xml · nonDerivative · entry 2

Lambert Nicole · CIK 0001770252 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,939

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009261 · wf-form4_167994884975705.xml · nonDerivative · entry 1

Lambert Nicole · CIK 0001770252 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,063

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009259 · wf-form4_167994883346896.xml · nonDerivative · entry 2

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,665

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009259 · wf-form4_167994883346896.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 373,972

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009258 · wf-form4_167994880541269.xml · nonDerivative · entry 2

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,218,631

F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009258 · wf-form4_167994880541269.xml · nonDerivative · entry 1

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,245,628

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023.

SEC source: 0001628280-23-009055 · wf-form4_167960339073835.xml · nonDerivative · entry 1

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,798

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023.

SEC source: 0001628280-23-009054 · wf-form4_167960337427659.xml · nonDerivative · entry 1

Ancona Margaret · CIK 0001843568 · SVP, Chief of Staff

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,272

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023.

SEC source: 0001628280-23-009051 · wf-form4_167960334155262.xml · nonDerivative · entry 1

Wong Pamela · CIK 0001885862 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,320

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023.

SEC source: 0001628280-23-009052 · wf-form4_167960335731267.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,772

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023.

SEC source: 0001628280-23-009050 · wf-form4_167960331971225.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,065

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023.

SEC source: 0001628280-23-009049 · wf-form4_167960329972877.xml · nonDerivative · entry 1

Verratti Mark · CIK 0001517026 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 266,076

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023.

SEC source: 0001628280-23-009047 · wf-form4_167960328178070.xml · nonDerivative · entry 1

Lambert Nicole · CIK 0001770252 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 252,206

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023.

SEC source: 0001628280-23-009045 · wf-form4_167960326581990.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 377,594

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023.

SEC source: 0001628280-23-009044 · wf-form4_167960325165880.xml · nonDerivative · entry 1

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,264,056

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023.

SEC source: 0001628280-23-008325 · wf-form4_167899873690419.xml · nonDerivative · entry 1

Ancona Margaret · CIK 0001843568 · SVP, Chief of Staff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,023

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-23-008324 · wf-form4_167899871320123.xml · nonDerivative · entry 1

Wong Pamela · CIK 0001885862 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,752

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-23-008323 · wf-form4_167899868751482.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 381,668

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-23-008322 · wf-form4_167899866500395.xml · nonDerivative · entry 1

Lambert Nicole · CIK 0001770252 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254,625

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-23-008321 · wf-form4_167899865022234.xml · nonDerivative · entry 1

DIAZ PAUL J · CIK 0001194247 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,284,102

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-23-008320 · wf-form4_167899860209122.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,171

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-23-008319 · wf-form4_167899858730951.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,742

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-23-008317 · wf-form4_167899857206258.xml · nonDerivative · entry 1

Munk Natalie · CIK 0001932320 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,186

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001628280-23-008316 · wf-form4_167899855540034.xml · nonDerivative · entry 1

Verratti Mark · CIK 0001517026 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,427

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001621899-23-000005 · wf-form4_167788121229192.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 337,885

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.50 to $22.63, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001770252-23-000002 · wf-form4_167788101472427.xml · nonDerivative · entry 1

Lambert Nicole · CIK 0001770252 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,220

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.50 to $22.97, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001472827-23-000006 · wf-form4_167779157228780.xml · nonDerivative · entry 1

Solaiman Shereen · CIK 0001472827 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,856

F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

SEC source: 0001843568-23-000001 · wf-form4_167753224751902.xml · nonDerivative · entry 1

Ancona Margaret · CIK 0001843568 · SVP, Chief of Staff

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,604

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 24, 2023.

SEC source: 0001843872-23-000001 · wf-form4_167753204919533.xml · nonDerivative · entry 1

Haas Kevin Richard · CIK 0001843872 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,283

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 24, 2023.

SEC source: 0001621899-23-000003 · wf-form4_167701522597948.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 352,885

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 17, 2023.

SEC source: 0001621899-23-000002 · wf-form4_167450842679054.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 364,107

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.12, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001621899-23-000001 · wf-form4_167416896780055.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 373,507

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.02, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001922964-23-000001 · wf-form4_167287373358897.xml · nonDerivative · entry 1

Muzzey Dale · CIK 0001922964 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,712

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 30, 2022.

SEC source: 0001770252-23-000001 · wf-form4_167287361378749.xml · nonDerivative · entry 1

Lambert Nicole · CIK 0001770252 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 228,404

F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 30, 2022.

SEC source: 0001621899-22-000008 · wf-form4_167226151057587.xml · nonDerivative · entry 1

Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 374,107

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.54, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001628280-22-027577 · wf-form4_166733465434274.xml · nonDerivative · entry 1

BISARO PAUL · CIK 0001237253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,875

F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant.